Table 1.
Description of newly admitted long-term care home residents meeting study inclusion and exclusion criteria by admission period.
Cohort selection step | 2018/2019 | 2019/2020 | Pandemic 2020/2021 |
---|---|---|---|
Total long-term care residents admitted within period and assessed with MDS 2.0 assessment | 39 854 | 39 997 | 26 228 |
Exclusions | |||
Age < 18 | 31 | 21 | 8 |
Comatose | 5 | 13 | 19 |
Expected short (<90 d) length of stay | 4136 | 3852 | 323 |
Met CIHI DRG01 quality indicator exclusion criteria (not mutually exclusive) | 4683 | 5094 | 4266 |
Schizophrenia | 15.9% | 14.1% | 12.4% |
Huntington’s disease | 1.8% | 1.1% | 1.2% |
End-stage disease | 25.5% | 26.4% | 28.6% |
Hospice care | 3.7% | 4.4% | 3.4% |
Hallucinations | 25.8% | 25.8% | 27.7% |
Delusions | 48.4% | 50.7% | 50.1% |
Total long-term care residents meeting primary study cohort inclusion criteria | 30 999 | 31 017 | 21 612 |
Total long-term care residents assessed with follow-up MDS 2.0 assessment 70-110 d later | 24 919 | 24 999 | 17 057 |
Exclusions | |||
Follow-up MDS 2.0 assessment occurred during subsequent period | 6269 | 5839 | 4375 |
Met CIHI DRG01 quality indicator exclusion criteria at follow-up (not mutually exclusive) | 1667 | 1800 | 1327 |
Schizophrenia | 2.0% | 2.1% | 1.7% |
Huntington’s disease | 0.2% | 0.2% | 0.2% |
End-stage disease | 30.8% | 31.2% | 34.1% |
Hospice care | 4.3% | 5.6% | 4.5% |
Hallucinations | 25.0% | 27.4% | 24.3% |
Delusions | 54.7% | 53.8% | 52.7% |
Total long-term care residents meeting secondary study cohort inclusion criteria | 16 983 | 16 860 | 11 355 |
DRG01 = Percentage of residents on antipsychotics without a diagnosis of psychosis.